Dyne Therapeutics Inc (DYN) Annual Balance Sheets

Annual · GAAP · USD millions
Access DYN quarterly Balance Sheets →
The table below presents a historical view of Dyne Therapeutics Inc's balance sheet, supporting analysis of financial position trends.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent893.37
Available-for-sale Securities, Debt Securities, Current MA217.19
Cash & Short-term Investments1,110.00
Prepaid Expense And Other Assets Current16.03
Total Current Assets1,126.59
Equipment/Property/Plant Net24.03
Operating Lease Right Of Use Asset20.74
Restricted Cash And Other Assets Noncurrent15.60
Total Assets1,186.96
Liabilities
Accounts Payable, Current AC8.08
Accrued Liabilities And Other Liabilities37.55
Other current liabilities5.00
Total Current Liabilities50.63
Long-term debt148.92
Total Long-term Debt148.92
Other longterm liabilities15.28
OperatingLeaseLiabilityNoncurrent15.28
Operating Lease Liability Current5.00
Total Liabilities214.83
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock2,367.78
Retained Earnings / Accumulated Deficit-1,396.14
Other Equity0.47
Common Stockholder's Equity972.13
Total Stockholder's Equity972.13
Liabilities & Stockholder's Equity1,186.96
4 historic quarters locked

Sign in to unlock the full Dyne Therapeutics Inc balance sheet history.

About Dyne Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 2, 2026
  • Source: dyn-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-084178

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.